Abiopharma

New Form F-6 - CSL LTD Filed: 2026-01-16 AccNo: 0000950127-26-000007 Size: 426 KB

Marquet Magda 🟡 adjusted position in 11.0K shares (1 derivative) of ANAPTYSBIO, INC (ANAB) at $48.85 ($1.1M) Transaction Date: Jan 15, 2026 | Filing ID: 000002

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjögren’s disease

New Form SCHEDULE 13G - Corbus Pharmaceuticals Holdings, Inc. Filed: 2026-01-16 AccNo: 0001716774-26-000003 Size: 8 KB

Coherent Named to Forbes 2026 America’s Best Companies List

Gevo Names Alex Clayton Chief Carbon Officer to Lead Gevo’s Carbon Market Expansion

OneMedNet Delivers a Real-World Data feed of 1.5M Patients consisting of 4M encounters

Volition Sponsors Symposium at Veterinary Meeting and Expo

Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million

Clene to Present at the Emerging Growth Conference

Palisade Bio Announces Two Abstracts Selected for Poster Presentations at Leading Global Inflammatory Bowel Disease Conferences

Star Equity Holdings to Present at Sidoti’s Micro-Cap Virtual Investor Conference on January 21-22

Clene to Present at the Emerging Growth Conference

A New Press Release from Elicio Therapeutics

New clinical data highlights CAPLYTA® (lumateperone) as a promising option for achieving remission in adults with major depressive disorder